The Chinese R&D Landscape – Biotechnology


June 1, 2012
13 Pages - SKU: KRFT3938013
License type:
Countries covered: China

R&D in China in the field of biotechnology* has surged over the last decade. This report seeks to answer the following questions related to this surge in R&D:
  • Where in China does the R&D in the field of biotechnology take place?
  • What companies and academic institutions in China are driving this R&D effort?
  • What has been the focus of Chinese R&D in the field of biotechnology?
The foundation for the study has been the complete database of Chinese invention patents and patent applications from the State Intellectual Property Office of China. This database has been supplemented with geographical data, thereby providing information on the ‘who’, ‘what’, ‘where’ and ‘when’ of invention in China. Only patents with Chinese priority have been included in the analysis, i.e. not patents filed elsewhere but extended to China.

The following information is included in the report:
  • The top 20 cities with regards to the number of patent applications in the field of biotechnology, along with the number of applications and share of all applications in each city.
  • The top 10 companies with regards to the number of patent applications in the field of biotechnology, along with the cities they are located in, number of patent applications, and main patenting area (defined by the main International Patent Classification assigned to their patents).
  • The top 10 academic institutions with regards to the number of patents applications in the field of biotechnology, along with the cities they are located in, their number of patent applications, and main patenting area (defined by the main International Patent Classification assigned to their patents).
  • The R&D focus in the field of biotechnology, illustrated with a structured word cloud with the words most frequently used in patent abstracts in the field.
  • The top 50 actors (including companies and academic institutions) in the field, with names and addresses in Chinese, as well as locations, number of patent applications, and main patenting area.
* The WIPO definition has been used, which includes patents with the main International Patent Classifications C07G, C07K, C12M, C12N, C12P, C12Q, C12R, C12S.



More Biotechnology reports by Kairos Future AB

The Chinese R&D Landscape - Analysis of Biological Material by Kairos Future AB
R&D in China in the field of analysis of biological materials* has surged over the last decade. This report seeks to answer the following questions ...
The Chinese R&D Landscape - Environmental Technology by Kairos Future AB
R&D in China in the field of environmental technology* has surged over the last decade. This report seeks to answer the following questions related to ...
See all reports like this >>

More China Biotechnology reports

Monoclonal Antibody Markets in China by Asia Market Information & Development Company
China's demand for monoclonal antibody has grown at a fast pace in the past decade. In the next five years, both production and demand will ...
Biomaterials China News 1304 by CCM International Limited
Biomaterials China News 1304 In March 2013, a series of policies related to the biomaterials industry were published in China. The Chinese government paid more ...
Biotechnology Products Markets in China by Asia Market Information & Development Company
China's demand for biotechnology products has grown at a fast pace in the past decade. In the next five years, both production and demand ...
Comparison of Biopharmaceutical Industry between China and India by JZMed, Inc.
It has been widely recognized that biopharmaceuticals have become not only a new class of therapeutics for those diseases previously treated with small molecule drugs ...
See all reports like this >>

More China reports

Eyewear in Hong Kong, China by Euromonitor International
Chinese mainland tourists with a preference for international spectacle brands are the key driver for high volume and value growth. Minimum wage ordinance passed in ...
D&B Country RiskLine Report: China by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: China by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Wine - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...
See all reports like this >>